Millions Excluded By Language Barrier From Clinical Trials

Oct 31, 2018, 12:01 by Michael Croft

NPR.org | In the U.S., Alzheimer's clinical trials are largely limited to fluent English speakers, which leaves millions of patients without the opportunity to participate and scientists without diverse data.

October 31, 2018 | In the U.S., Alzheimer's clinical trials are largely limited to fluent English speakers, which leaves millions of patients without the opportunity to participate and scientists without diverse data. NPR.org